After two and a half seasons of playing the best basketball of his career, former Net Cameron Johnson is headed west, hoping to be the missing piece on a potent ...

When his colleagues think of the kind of judge that the Honorable Theodore O. Johnson was, they all had this to say in common ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Peyton Johnson joined WCTV's Taylor Viles for a three-hole scramble match interview. They talked about the high school junior ...

The party is seeking a pathway back to power in Washington but is grappling for a message that will resonate with the working ...

In the assessment of 12-month price targets, analysts unveil insights for Johnson & Johnson, presenting an average target of $168.25, a high estimate of $181.00, and a low estimate of $153.00.

Johnson & Johnson's 2025 outlook sees slight EPS and revenue upgrades, while headwinds from biosimilars and tariffs are ...

JNJ which has outperformed the S&P 500 and other large-cap healthcare peers in H1-2025, now faces a crucial test with Q2 ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Johnson & Johnson (JNJ) reports results for ...

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

Johnson & Johnson has asked a federal judge in Central California for a judgment as a matter of law to throw out a jury's ...